There is, I think, a strong argument that the IMO process could be used in order to give effect to the fourth dose, and, therefore, we are potentially legislating for no good reason, and that is one of the issues that I think should be explored at the select committee, which is: is the bill absolutely necessary? Because it's a pretty unusual thing that we're doing. We are, essentially, amending the Medicines Act, not under urgency—well, this bill has been taken under urgency, but we will not pass it under urgency. But it's a pretty unusual thing to have a very truncated select committee process to amend a pretty significant piece of legislation in New Zealand—and a very short piece of legislation: five clauses only. And so a pretty unusual situation, but we do find ourselves in pretty unusual times. 